Search Results - "electrical cardioversion"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation by N. A. Novikova, A. N. Volovchenko

    Published 2016-11-01

    Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic stroke. The risk of thromboembolic complications increases significantly when performing for electrical cardioversion. Vitamin K antagonists (warfarin) more often used to prepare for electrical cardiover...

    Full description

    Subjects: Get full text
    Article
  2. 2

    Efficiency of Electrical Cardioversion of Paroxysmal Atrial Fibrillation in the Use of Bipolar QuasiSinusoidal Impulse in Patients with Coronary Heart Disease by V. A. Vostrikov, K. V. Razumov

    Published 2014-06-01

    Objective: to study the dose-dependent efficacy of bipolar quasisinusoidal (BPQS) impulse in eliminating 24—48-hour atrial  fibrillation  (AF)  in  patients  with  different  clinical  forms  and  course  of  coronary  heart  disease  (CHD)  and  different transthoracic  resistance  (TTR). Subjects ...

    Full description

    Subjects: “…electrical cardioversion, bipolar quasi-sinusoidal impulse, atrial fibrillation…”
    Get full text
    Article
  3. 3

    Takotsubo syndrome in a patient with atrial fibrillation after electrical cardioversion: a case report by E. S. Sitkova, A. V. Smorgon, R. E. Batalov, A. A. Andreev, S. V. Popov

    Published 2022-12-01

    The paper presents a description of the diagnosis and treatment of takotsubo syndrome in a patient with paroxysmal atrial fibrillation after electrical cardioversion. A case report clearly reflects the need for an integrated diagnostic approach to verify the diagnosis using dynamic echocardiography,...

    Full description

    Subjects: Get full text
    Article
  4. 4

    Methods of sinus rhythm restoration in patients with persistent and long-standing persistent atrial fibrillation by L. M. Kalmanson, E. I. Barashkova, I. V. Shlyk

    Published 2025-06-01

    The objective was to analyze modern approaches to the use of electrical and pharmacological cardioversion in patients with persistent atrial fibrillation (AF).Materials and methods. A non-systematic literature review was conducted. Russian publications were searched in the eLibrary database, and int...

    Full description

    Subjects: Get full text
    Article
  5. 5

    Direct oral anticoagulants for electrical cardioversion by A. N. Volovchenko, D. A. Andreev, D. F. Mesitskaya

    Published 2021-07-01

    The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using direct oral anticoagulants for this purpose i...

    Full description

    Subjects: Get full text
    Article
  6. 6

    CARDIOVERSION WITH BI- AND MONOPHASE DEFIBRILLATORS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION by V. A. Lusov, I. A. Kokorin, V. A. Kokorin, N. A. Volov, A. P. Goncharov

    Published 2010-02-01

    The paper focuses on the effectiveness and safety of bi- and monophase defibrillators in patients with paroxysmal atrial fibrillation. In bi-phase defibrillator cardioversion, sinus rhythm was restored more often, and total defibrillation energy was substantially lower than in monophase defibrillato...

    Full description

    Subjects: Get full text
    Article
  7. 7

    Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome by E. I. Barashkova, V. A. Ionin, E. I. Baranova

    Published 2024-06-01

    Aim. To evaluate the effect of blood concentrations of biomarkers of inflammation and fibrosis, obesity parameters, and parameters characterizing cardiac remodeling on the risk of recurrent atrial fibrillation (AF) within 6 months after elective electrical cardioversion (ECV) in patients with metabo...

    Full description

    Subjects: Get full text
    Article
  8. 8

    Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion by Kh. M. Dzaurova, N. Yu. Mironov, Yu. A. Yuricheva, M. M. Belyaeva, S. F. Sokolov, N. A. Mironova, S. P. Golitsyn, O. Yu. Korennova, I. M. Zueva, E. A. Turusheva, D. S. Terekhov

    Published 2025-06-01

    Aim. To evaluate the effectiveness and safety of cavutilide in patients with a history of unsuccessful cardioversion to terminate current persistent and paroxysmal atrial fibrillation (AF) episode.Material and methods. The retrospective study included 55 patients (mean age 60±8 years; male/female ra...

    Full description

    Subjects: Get full text
    Article
  9. 9

    Assessment of the Degree of Left Atrial Fibrosis in Patients with Different Forms of Atrial Fibrillation by Eugene O. Perepeka, Elina V. Bodnarevska, Mykhailo S. Ishchenko, Borys B. Kravchuk

    Published 2025-06-01

    Atrial fibrillation (AF) is the most common type of cardiac arrhythmia, which has a significant impact on the health of patients worldwide. Left atrial fibrosis (LAF) is considered an irreversible form of remodeling that occurs in response to inflammation, stretching, or overload of the left atrium....

    Full description

    Subjects: Get full text
    Article
  10. 10

    Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment by Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova

    Published 2018-09-01

    Atrial fibrillation (AF) is the most common tachyarrhythmia complicating ST segment elevation myocardial infarction (STEMI), while ventricular arrhythmias (VA) can, not only be accompanied by a hemodynamic disorder, but in some cases, worsen its prognosis. The article presents a modern view on risk...

    Full description

    Subjects: Get full text
    Article
  11. 11

    2020 Clinical guidelines for Atrial fibrillation and atrial flutter by M. G. Arakelyan, L. A. Bockeria, E. Yu. Vasilieva, S. P. Golitsyn, E. Z. Golukhova, M. V. Gorev, K. V. Davtyan, O. M. Drapkina, E. S. Kropacheva, E. A. Kuchinskaya, L. Yu. Lajovich, N. Yu. Mironov, I. E. Mishina, E. P. Panchenko, A. Sh. Revishvili, F. G. Rzayev, B. A. Tatarsky, M. D. Utsumueva, O. O. Shakhmatova, N. B. Shlevkov, A. V. Shpektor, D. A. Andreev, E. A. Artyukhina, O. L. Barbarash, A. S. Galyavich, D. V. Duplyakov, S. A. Zenin, D. S. Lebedev, E. N. Mikhailov, N. A. Novikova, S. V. Popov, A. G. Filatov, E. V. Shlyakhto, Yu. V. Shubik

    Published 2021-08-01

    Russian Society of Cardiology (RSC).With the participation of Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Cardiac Pacing, Russian Association of Cardiovascular Surgeons.Approved by the Scientific and Practical Council of the Russian Ministry of Health.

    Subjects: Get full text
    Article